Familial dyslipidaemias: an overview of genetics, pathophysiology and management (Q36651652)

15 August 2017

1 reference

title

Familial dyslipidaemias: an overview of genetics, pathophysiology and management (English)

1 reference

15 August 2017

1 reference

Sahar B Hachem

1

1 reference

15 August 2017

Arshag D Mooradian

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

66

1 reference

15 August 2017

issue

15

1 reference

15 August 2017

page(s)

1949-1969

1 reference

Alcohol and atherosclerosis

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666150-00005

1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666150-00005

Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666150-00005

An overview of reverse cholesterol transport.

21 January 2018

1 reference

12 December 2020

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

1 reference

12 December 2020

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

1 reference

12 December 2020

Scavenger receptor BI and cholesterol trafficking

1 reference

12 December 2020

Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype

1 reference

12 December 2020

Lipid disturbances in endocrine disorders

1 reference

12 December 2020

1 reference

12 December 2020

Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison

1 reference

12 December 2020

Drug treatment of lipid disorders

1 reference

12 December 2020

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

1 reference

12 December 2020

Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

1 reference

12 December 2020

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

12 December 2020

The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus

1 reference

12 December 2020

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice

1 reference

12 December 2020

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

1 reference

12 December 2020

Serum lipids in acromegaly

1 reference

12 December 2020

Safety and efficacy of Omacor in severe hypertriglyceridemia

1 reference

12 December 2020

A receptor-mediated pathway for cholesterol homeostasis

1 reference

12 December 2020

Cardiovascular disease in type 2 diabetes mellitus: current management guidelines

1 reference

12 December 2020

Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia

1 reference

12 December 2020

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

1 reference

12 December 2020

Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype

1 reference

12 December 2020

Very-low-density lipoprotein assembly and secretion

1 reference

12 December 2020

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

1 reference

12 December 2020

Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy

1 reference

12 December 2020

Focus on lifestyle change and the metabolic syndrome

1 reference

12 December 2020

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

12 December 2020

1 reference

12 December 2020

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

12 December 2020

Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways

1 reference

12 December 2020

Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A

1 reference

12 December 2020

Oral Contraceptive and Postmenopausal Estrogen Effects on Lipoprotein Triglyceride and Cholesterol in an Adult Female Population: Relationships to Estrogen and Progestin Potency*

1 reference

12 December 2020

Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association

1 reference

12 December 2020

Homozygous Tangier disease and cardiovascular disease

1 reference

12 December 2020

Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.

1 reference

12 December 2020

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

1 reference

12 December 2020

Neonatal pancreatitis associated with familial lipoprotein lipase deficiency

1 reference

12 December 2020

Lipids in type 2 diabetes

1 reference

12 December 2020

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia

1 reference

12 December 2020

Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia

1 reference

12 December 2020

Secondary causes of hyperlipidemia.

1 reference

12 December 2020

Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice

1 reference

12 December 2020

Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands

1 reference

12 December 2020

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

1 reference

12 December 2020

The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target

1 reference

12 December 2020

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

12 December 2020

Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia

1 reference

12 December 2020

Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects

1 reference

12 December 2020

Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and h

1 reference

12 December 2020

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia

1 reference

12 December 2020

Clinical practice. Low HDL cholesterol levels

1 reference

12 December 2020

Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.

1 reference

12 December 2020

Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the f

1 reference

12 December 2020

Drugs causing dyslipoproteinemia

1 reference

12 December 2020

Hypothyroidism and dyslipidemia: modern concepts and approaches

1 reference

12 December 2020

Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism

1 reference

12 December 2020

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

1 reference

12 December 2020

Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met)

1 reference

12 December 2020

n-3 fatty acids and serum lipoproteins: human studies

1 reference

12 December 2020

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis

1 reference

12 December 2020

Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides

1 reference

12 December 2020

Lipoprotein metabolism in subjects with hepatic lipase deficiency.

1 reference

12 December 2020

Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice

1 reference

12 December 2020

Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

1 reference

12 December 2020

Primary and familial hypoalphalipoproteinemia

1 reference

12 December 2020

Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene

1 reference

12 December 2020

Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?

1 reference

12 December 2020

Homozygous familial hypercholesterolemia and its management

1 reference

12 December 2020

Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome

1 reference

12 December 2020

PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene

1 reference

12 December 2020

The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

1 reference

12 December 2020

Heterozygous apolipoprotein C-II deficiency: lipoprotein and apoprotein phenotype and RsaI restriction enzyme polymorphism in the Apo C-IIPadova kindred.

1 reference

12 December 2020

Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia

1 reference

12 December 2020

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

1 reference

12 December 2020

Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease

1 reference

12 December 2020

Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II

1 reference

12 December 2020

Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

1 reference

12 December 2020

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency

1 reference

12 December 2020

Regulation of lipid and lipoprotein metabolism by retinoids

1 reference

12 December 2020

Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes

1 reference

12 December 2020

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

1 reference

12 December 2020

1 reference

12 December 2020

Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency

1 reference

12 December 2020

Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy

1 reference

12 December 2020

Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.

1 reference

12 December 2020

Structure, function and role of lipoprotein lipase in lipoprotein metabolism

1 reference

12 December 2020

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

1 reference

12 December 2020

10.2165/00003495-200666150-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1013375175

0 references

1 reference